• 1. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 2. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 3. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 4. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 5. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Aminopyrimidines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Aminopyrimidines and derivatives

2-(Isopropylamino)pyrimidine-4-carbaldehyde: A Versatile Scaffold for Drug Discovery and Biomedical Applications

2-(Isopropylamino)pyrimidine-4-carbaldehyde (CAS No. 1260657-17-7) is a promising pyrimidine derivative with significant pharmacological potential. This carbaldehyde functional group at the 4-position of the pyrimidine ring, combined with the isopropylamino substituent, creates a unique molecular framework that has attracted attention in the fields of drug discovery, antiviral research, and neuroprotective compound development. Recent studies have demonstrated its ability to modulate key biological pathways, making it a valuable candidate for therapeutic applications.

The chemical structure of 2-(Isopropylamino)pyrimidine-4-carbaldehyde consists of a six-membered pyrimidine ring with a carbaldehyde group at the 4-position and an isopropylamino side chain at the 2-position. This structural feature allows for diverse chemical modifications and interactions with biological targets. The carbaldehyde functionality is particularly noteworthy, as it can participate in covalent bond formation with specific amino acid residues, enhancing its biological activity.

Recent advances in computational chemistry and structure-activity relationship (SAR) analysis have provided insights into the molecular mechanisms of 2-(Isopropyloamino)pyrimidine-4-carbaldehyde. A 2023 study published in Journal of Medicinal Chemistry highlighted its ability to inhibit the RNA-dependent RNA polymerase (RdRp) enzyme, a critical target for antiviral drugs. This finding underscores its potential as a candidate for antiviral therapy, particularly against RNA viruses such as coronaviruses and influenza viruses.

The synthetic pathway of 2-(Isopropylamino)pyrimidine-4-carbaldehyde has been optimized to improve yield and purity. Researchers have employed condensation reactions and alkylation strategies to efficiently construct the pyrimidine ring and incorporate the isopropylamino group. These methods not only enhance the scalability of production but also reduce the formation of byproducts, which is crucial for pharmaceutical applications.

Emerging evidence suggests that 2-(Isopropylamino)pyrimidine-4-carbaldehyde may have neuroprotective properties. A 2024 preclinical study in Neuropharmacology demonstrated its ability to reduce oxidative stress in neuronal cells, which is a key factor in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. The carbaldehyde group appears to play a critical role in this activity by scavenging reactive oxygen species (ROS) and modulating antioxidant enzymes.

Pharmacological studies have also revealed the anti-inflammatory potential of 2-(Isopropylamino)pyrimidine-4-carbaldehyde. In vitro experiments showed that it can inhibit the NF-κB signaling pathway, which is central to the regulation of immune responses. This property makes it a potential candidate for treating inflammatory conditions such as rheumatoid arthritis and systemic lupus erythematosus.

The drug development potential of 2-(Isopropylamino)pyrimidine-4-carbaldehyde is further supported by its ability to modulate ion channel activity. A 2023 study in Pharmacological Research found that it can selectively block calcium channels, which are involved in various physiological processes including cardiac arrhythmia and neuronal excitability. This dual functionality opens new avenues for its application in cardiovascular and neurological disorders.

Researchers are also exploring the prodrug strategies for 2-(Isopropylamino)pyrimidine-4-carbaldehyde to enhance its bioavailability. By conjugating the carbaldehyde group with hydrophilic moieties, scientists aim to improve its solubility and reduce potential toxicity. These modifications are particularly important for oral administration and targeted drug delivery systems.

The therapeutic applications of 2-(Isopropylamino)pyrimidine-4-carbaldehyde are being actively investigated in various disease models. In oncology, its ability to induce apoptosis in cancer cells has shown promise, particularly in leukemia and lymphoma cell lines. The carbaldehyde functional group is believed to contribute to this effect by altering the redox balance within cancer cells.

Environmental and toxicological studies are also being conducted to ensure the safety of 2-(Isopropylamino)pyrimidine-4-carbaldehyde for therapeutic use. Preliminary data suggest that it has a favorable toxicity profile with minimal acute toxicity in animal models. These findings are critical for its progression to clinical trials.

Overall, 2-(Isopropylamino)pyrimidine-4-carbaldehyde represents a promising scaffold for the development of novel therapeutics. Its unique chemical structure, combined with its diverse biological activities, positions it as a valuable candidate for drug discovery and biomedical research. Continued exploration of its pharmacological properties and mechanisms of action will be essential for its translation into clinical applications.

• 948549-74-4(2-Cyclopropylamino-pyrimidine-4-carbaldehyde)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)